S'abonner

How to address SARS-CoV-2 airborne transmission to ensure effective protection of healthcare workers? A review of the literature - 05/08/21

Doi : 10.1016/j.idnow.2021.05.005 
Sara Romano-Bertrand a, b, c, , Yolène Carré a, d, Ludwig-Serge Aho Glélé a, e, Didier Lepelletier a, f
on behalf of the

Scientific Committee of the French Society for Hospital Hygiene

a French Society for Hospital Hygiene, France 
b HydroSciences Montpellier, IRD, CNRS, Montpellier University, Montpellier, France 
c Hospital, Hygiene and Infection Control Team, University Hospital of Montpellier, 34000 Montpellier, France 
d CHU de Bordeaux, Pôle de Santé Publique, Infection Control Unit, 33000 Bordeaux, France 
e Epidemiology and Hospital Hygiene Department, Dijon University Hospital, 21079 Dijon, France 
f Hospital Hygiene Department, Nantes University Hospital, 44000 Nantes, France 

Corresponding author at: UMR 5569 HSM, Équipe Pathogènes Hydriques Santé et Environnements, U.F.R. des Sciences Pharmaceutiques et Biologiques, Université Montpellier, 15, avenue Charles Flahault, BP 14491, 34093 Montpellier cedex 5, France.UMR 5569 HSM, Équipe Pathogènes Hydriques Santé et Environnements, U.F.R. des Sciences Pharmaceutiques et Biologiques, Université Montpellier15, avenue Charles Flahault, BP 14491Montpellier cedex 534093France

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Highlights

Various definitions of airborne-related terminology have generated confusion. An aerosol can contain both liquid (droplets) and solid (droplet nuclei) particles of various sizes.
Respiratory activities produce aerosols containing a wide spectrum of particles in highly variable sizes and loads. Differentiation of “droplets” from “air” transmission fails to reflect the complexity of respiratory pathogen transmission.
Environmental factors condition the risk of transmission of the pathogens present in aerosols, which are not transposable between one another. Small particles of matter serve as a vector for SARS-CoV-2 virions and facilitate their spread and/or introduction in the lower airways.
Molecular detection of SARS-CoV-2 in environmental samples should amplify 2 or 3 targets, in the same manner as biologic samples. Results should be interpreted carefully as long as no active replication has occurred in the environment.
SARS-CoV-2 infectiousness from environmental samples in healthcare settings (excluding experimental contexts) has yet to be demonstrated.
Current scientific evidence suggests that surgical and N95/FFP2 masks confer equivalent protection against airborne viral infections to HCWs engaged in routine care. Although SARS-CoV-2 virion is a nanoparticle, it is usually carried by larger particles, which are easily stopped and contained by a mask.
Airborne transmission seems to occur under specific circumstances with high viral density, which is more common in community than in healthcare facilities.
While airborne transmission is possible, the major route of transmission in healthcare settings is droplet-mediated.

Le texte complet de cet article est disponible en PDF.

Abstract

SARS-CoV-2 mainly infects the respiratory tract, and presents significantly higher active replication in the upper airways. To remain viable and infectious, the SARS-CoV-2 virion must be complete and integral, which is not easily demonstrated in the environment by positive reverse transcriptase PCR results. Real-life conditions in healthcare settings may be conducive to SARS-CoV-2 RNA dissemination in the environment but without evidence of its viability and infectiveness in air. Theoretically, SARS-CoV-2 shedding and dissemination nonetheless appears to be air-mediated, and a distinction between “air” and “droplet” transmission is too schematic to reflect the reality of the respiratory particles emitted by patients, between which a continuum exists. Airborne transmission is influenced by numerous environmental conditions that are not transposable between different viral agents and situations in healthcare settings or in the community. Even though international guidelines on “droplet” versus “air” precautions and personal protective equipment (surgical versus respirator masks) are under discussion, the existing literature underscores the effectiveness of “droplet” precautions as a means of protecting healthcare workers. Differentiation in guidelines between healthcare venues, community settings and, more generally, confined environments is of paramount importance, especially insofar as it underlines the abiding pandemic-related need for systematic mask wearing by the general population.

Le texte complet de cet article est disponible en PDF.

Keywords : COVID-19, Infection control, Pandemic, Aerosol, Mask


Plan


© 2021  Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 51 - N° 5

P. 410-417 - août 2021 Retour au numéro
Article précédent Article précédent
  • Why should the meningococcal B vaccine be recommended, and therefore reimbursed, for infants in France?
  • Christèle Gras-Le Guen, Nicolas Vignier, Fabienne Kochert, Etienne Javouhey, Elise Launay, Véronique Dufour, Joël Gaudelus, Odile Launay, Jean Paul Stahl, Pierre Tattevin, Robert Cohen
| Article suivant Article suivant
  • Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap?
  • Robert Cohen, Marion Ashman, Muhamed-Kheir Taha, Emmanuelle Varon, François Angoulvant, Corinne Levy, Alexis Rybak, Naim Ouldali, Nicole Guiso, Emmanuel Grimprel

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.